Our study demonstrated that Faf2 knockdown significantly reduced PCSK9 expression at both mRNA and protein levels, indicating that FAF2 may regulate PCSK9 expression and, thus, play a critical role in the development of liver steatosis. This evidence concerns the gene PCSK9 and fatty liver disease.